Skip to main content

Table 1 Clinical and demographic features of participants

From: White matter and cortical gray matter microstructural alterations in migraine: a NODDI and DTI analysis

 

Controls (n = 45)

EM (n = 35)

CM (n = 40)

P-value

Ages (years)

35(19)

37(20)

39.50(30.50)

0.843a

BMI (kg/m2)

23.15(4.15)

22.23(4.60)

23.95(3.53)

0.207a

Gender (female/male)

27/18

23/12

29/11

0.479b

Headache history (years)

NA

11(16)

11(18.25)

0.463c

Pain intensity VAS score

NA

7(2)

7(2.75)

0.314c

HIT-6 score

NA

65.23 ± 7.53

66.05 ± 6.76

0.62d

PHQ-9 score

NA

4(7)

9(8.75)

<0.001c

GAD-7 score

NA

3(5)

6(8.5)

0.024c

PSQI score

NA

8.03 ± 4.59

10.73 ± 5.29

0.022d

MoCA score

NA

28(3)

28(4)

0.957c

MIDAS score

NA

48(46)

83.5(119.25)

0.001c

  1. Note: NA, not applicable; BMI, body mass index; VAS, Visual Analogue Scale; PHQ-9, Patient Health Questionnaire-9; GAD-7, Generalized Anxiety Disorder-7; PSQI, Pittsburgh Sleep Quality Index; HIT-6, Headache Impact Test-6; MoCA, Montreal Cognitive Assessment; MIDAS, Migraine Disability Assessment Scale
  2. Data are presented as mean ± standard deviation or as median [interquartile range, IQR]
  3. a Kruskal-Wallis H test
  4. b Chi-square test
  5. c Mann–Whitney U test
  6. d Independent Samples t test